David John King

Title: David John King - Innovator in Antigen-Binding Proteins

Introduction

David John King is a notable inventor based in Bagshot, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding proteins. His work is crucial for advancements in medical treatments and diagnostics.

Latest Patents

David John King holds a patent for "Tri- and tetra-valent monospecific antigen-binding proteins." This invention provides a tri- or tetra-valent monospecific antigen-binding protein comprising three or four Fab fragments bound to each other covalently by a connecting structure. Notably, this protein is not a natural immunoglobulin. The invention also includes novel connecting structures for assembling the proteins and means for attaching a labeling or effector group. These proteins are particularly useful in the treatment and diagnosis of cancer.

Career Highlights

David John King is associated with Celltech R&D Limited, where he continues to innovate in the field of biotechnology. His work has the potential to impact cancer treatment significantly, showcasing his dedication to improving healthcare through scientific advancements.

Collaborations

Some of his coworkers include Alison Turner and Nigel Robert Arnold Beeley. Their collaboration contributes to the innovative environment at Celltech R&D Limited.

Conclusion

David John King is a prominent inventor whose work in antigen-binding proteins is paving the way for new cancer treatments. His contributions to biotechnology are invaluable and highlight the importance of innovation in healthcare.